CALDER_PHARMACY_LIMITED - Accounts

Company Registration No. SC268645 (Scotland)
CALDER PHARMACY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2020
PAGES FOR FILING WITH REGISTRAR
CALDER PHARMACY LIMITED
COMPANY INFORMATION
Directors
Mr C Shanks
Secretary
Ms D Holmes
Company number
SC268645
Registered office
18 Calder Park
Edinburgh
EH11 4JN
Accountants
Geoghegans Accountancy Limited
Chartered Accountants
6 St Colme Street
Edinburgh
EH3 6AD
CALDER PHARMACY LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
CALDER PHARMACY LIMITED
BALANCE SHEET
AS AT
31 AUGUST 2020
31 August 2020
- 1 -
2020
2019
Notes
£
£
£
£
Fixed assets
Intangible assets
58,400
73,000
Tangible assets
4
58,663
76,803
Investment properties
5
582,534
340,404
Investments
6
31,296
20,196
730,893
510,403
Current assets
Stocks
23,245
18,197
Debtors
7
258,103
218,055
Cash at bank and in hand
159,889
204,640
441,237
440,892
Creditors: amounts falling due within one year
8
(207,382)
(67,386)
Net current assets
233,855
373,506
Total assets less current liabilities
964,748
883,909
Creditors: amounts falling due after more than one year
9
(231,325)
(227,199)
Provisions for liabilities
(11,146)
(13,057)
Net assets
722,277
643,653
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss reserves (non-distributable)
18,506
18,506
Profit and loss reserves
702,771
624,147
Total equity
722,277
643,653

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 August 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

CALDER PHARMACY LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 AUGUST 2020
31 August 2020
- 2 -

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 12 February 2021
Mr C  Shanks
Director
Company Registration No. SC268645
CALDER PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2020
- 3 -
1
Accounting policies
Company information

Calder Pharmacy Limited is a private company limited by shares incorporated in Scotland. The registered office is 18 Calder Park, Edinburgh, EH11 4JN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 20 years.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
15% on reducing balance
Motor vehicles
25% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Investment properties

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.

1.6
Impairment of fixed assets

The carrying value of tangible fixed assets are reviewed for impairment when events or changes in circumstances indicate that the carrying value may not be recoverable.

CALDER PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
1
Accounting policies
(Continued)
- 4 -
1.7
Stocks

Stocks are stated at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost is determined on a first-in. first-out basis. Net realisable value is based on estimated selling price, less any further costs of realisation.

1.8
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Debtors

Debtors with no stated interest rate or receivable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account.

Creditors

Creditors with no stated interest rate and payable within one year are recorded at transaction price.

 

All interest bearing loans and borrowings which are basic financial instruments are initially recorded at the present value of cash payable. After initial recognition they are measured at amortised cost.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

CALDER PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
1
Accounting policies
(Continued)
- 5 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Leases

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

1.15
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2020
2019
Number
Number
Total
8
8
CALDER PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
- 6 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 September 2019 and 31 August 2020
292,000
Amortisation and impairment
At 1 September 2019
219,000
Amortisation charged for the year
14,600
At 31 August 2020
233,600
Carrying amount
At 31 August 2020
58,400
At 31 August 2019
73,000
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 September 2019
110,717
Additions
1,967
At 31 August 2020
112,684
Depreciation and impairment
At 1 September 2019
33,914
Depreciation charged in the year
20,107
At 31 August 2020
54,021
Carrying amount
At 31 August 2020
58,663
At 31 August 2019
76,803
5
Investment property
2020
£
Fair value
At 1 September 2019
340,404
Additions
242,130
At 31 August 2020
582,534
CALDER PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
5
Investment property
(Continued)
- 7 -

Investment property comprises three properties held to earn rental income.

6
Fixed asset investments
2020
2019
£
£
Other investments other than loans
31,296
20,196
Movements in fixed asset investments
Investments other than loans
£
Cost or valuation
At 1 September 2019
20,196
Additions
11,100
At 31 August 2020
31,296
Carrying amount
At 31 August 2020
31,296
At 31 August 2019
20,196
7
Debtors
2020
2019
Amounts falling due within one year:
£
£
Trade debtors
119,596
70,170
Corporation tax and other taxation
-
7,760
Other debtors
138,507
140,125
258,103
218,055
8
Creditors: amounts falling due within one year
2020
2019
£
£
Bank loans and overdrafts
28,015
28,049
Trade creditors
36,379
31,676
Corporation tax, other taxation and social security
12,303
1,008
Other creditors
130,685
6,653
207,382
67,386
CALDER PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2020
- 8 -
9
Creditors: amounts falling due after more than one year
2020
2019
£
£
Bank loans and overdrafts
181,325
227,199
Other creditors
50,000
-
231,325
227,199

The aggregate amount of creditors for which security has been given amounted to £186,044 (2019 - £226,959).

 

The Royal Bank of Scotland PLC has a bond and floating charge over the undertaking and all property and assets present and future.

 

The Royal Bank of Scotland PLC holds a fixed charge over the property at Leyland Road and another over the property at Sighthill Park.

10
Related party transactions

Included in other debtors is a balance of £98,420 (2019: £104,009) owed by Mr C Shanks, director of the company. Interest is charged at 2.5%.

2020-08-312019-09-01false12 February 2021CCH SoftwareCCH Accounts Production 2020.310No description of principal activityMr C ShanksMr C ShanksMs D HolmesSC2686452019-09-012020-08-31SC268645bus:Director12019-09-012020-08-31SC268645bus:CompanySecretary12019-09-012020-08-31SC268645bus:Director22019-09-012020-08-31SC268645bus:RegisteredOffice2019-09-012020-08-31SC2686452020-08-31SC268645core:NetGoodwill2020-08-31SC268645core:NetGoodwill2019-08-31SC2686452018-09-012019-08-31SC2686452019-08-31SC268645core:OtherPropertyPlantEquipment2020-08-31SC268645core:OtherPropertyPlantEquipment2019-08-31SC268645core:CurrentFinancialInstrumentscore:WithinOneYear2020-08-31SC268645core:CurrentFinancialInstrumentscore:WithinOneYear2019-08-31SC268645core:CurrentFinancialInstruments2020-08-31SC268645core:CurrentFinancialInstruments2019-08-31SC268645core:Non-currentFinancialInstruments2020-08-31SC268645core:Non-currentFinancialInstruments2019-08-31SC268645core:ShareCapital2020-08-31SC268645core:ShareCapital2019-08-31SC268645core:OtherMiscellaneousReserve2020-08-31SC268645core:OtherMiscellaneousReserve2019-08-31SC268645core:RetainedEarningsAccumulatedLosses2020-08-31SC268645core:RetainedEarningsAccumulatedLosses2019-08-31SC268645core:Goodwill2019-09-012020-08-31SC268645core:FurnitureFittings2019-09-012020-08-31SC268645core:MotorVehicles2019-09-012020-08-31SC268645core:NetGoodwill2019-08-31SC268645core:NetGoodwill2019-09-012020-08-31SC268645core:OtherPropertyPlantEquipment2019-08-31SC268645core:OtherPropertyPlantEquipment2019-09-012020-08-31SC2686452019-08-31SC268645core:WithinOneYear2020-08-31SC268645core:WithinOneYear2019-08-31SC268645bus:PrivateLimitedCompanyLtd2019-09-012020-08-31SC268645bus:SmallCompaniesRegimeForAccounts2019-09-012020-08-31SC268645bus:FRS1022019-09-012020-08-31SC268645bus:AuditExemptWithAccountantsReport2019-09-012020-08-31SC268645bus:FullAccounts2019-09-012020-08-31xbrli:purexbrli:sharesiso4217:GBP